Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 2
1951 1
1952 5
1953 6
1954 1
1955 10
1956 5
1957 3
1958 8
1959 2
1964 6
1965 5
1966 7
1967 13
1968 18
1969 7
1970 13
1971 4
1972 8
1973 17
1974 14
1975 11
1976 7
1977 9
1978 6
1979 7
1980 6
1981 7
1982 23
1983 16
1984 13
1985 15
1986 17
1987 20
1988 21
1989 17
1990 15
1991 17
1992 12
1993 21
1994 16
1995 15
1996 25
1997 22
1998 22
1999 15
2000 20
2001 24
2002 22
2003 26
2004 34
2005 28
2006 22
2007 22
2008 22
2009 27
2010 18
2011 30
2012 49
2013 44
2014 67
2015 52
2016 48
2017 46
2018 51
2019 31
2020 51
2021 44
2022 49
2023 42
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

1,291 results

Results by year

Filters applied: . Clear all
Page 1
Minimal Change Disease.
Vivarelli M, Massella L, Ruggiero B, Emma F. Vivarelli M, et al. Clin J Am Soc Nephrol. 2017 Feb 7;12(2):332-345. doi: 10.2215/CJN.05000516. Epub 2016 Dec 9. Clin J Am Soc Nephrol. 2017. PMID: 27940460 Free PMC article. Review.
Interventions for minimal change disease in adults with nephrotic syndrome.
Azukaitis K, Palmer SC, Strippoli GF, Hodson EM. Azukaitis K, et al. Cochrane Database Syst Rev. 2022 Mar 1;3(3):CD001537. doi: 10.1002/14651858.CD001537.pub5. Cochrane Database Syst Rev. 2022. PMID: 35230699 Free PMC article. Review.
Studies in the Register are identified through searches of CENTRAL, MEDLINE, and EMBASE, conference proceedings, the International Clinical Trials Register (ICTRP) Search Portal and ClinicalTrials.gov. SELECTION CRITERIA: Randomised controlled trials (RCTs) and quas …
Studies in the Register are identified through searches of CENTRAL, MEDLINE, and EMBASE, conference proceedings, the International Clinic …
Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome.
Ruggenenti P, Ruggiero B, Cravedi P, Vivarelli M, Massella L, Marasà M, Chianca A, Rubis N, Ene-Iordache B, Rudnicki M, Pollastro RM, Capasso G, Pisani A, Pennesi M, Emma F, Remuzzi G; Rituximab in Nephrotic Syndrome of Steroid-Dependent or Frequently Relapsing Minimal Change Disease Or Focal Segmental Glomerulosclerosis (NEMO) Study Group. Ruggenenti P, et al. J Am Soc Nephrol. 2014 Apr;25(4):850-63. doi: 10.1681/ASN.2013030251. Epub 2014 Jan 30. J Am Soc Nephrol. 2014. PMID: 24480824 Free PMC article. Clinical Trial.
The outcome of steroid-dependent or frequently relapsing nephrotic syndrome of minimal change disease (MCD), mesangial proliferative GN (MesGN), or FSGS may be poor and with major treatment toxicity. This academic, multicenter, off-on trial (ClinicalTrials.gov #NCT00981838 …
The outcome of steroid-dependent or frequently relapsing nephrotic syndrome of minimal change disease (MCD), mesangial proliferative GN (Mes …
Randomized, Controlled Trial of Tacrolimus and Prednisolone Monotherapy for Adults with De Novo Minimal Change Disease: A Multicenter, Randomized, Controlled Trial.
Medjeral-Thomas NR, Lawrence C, Condon M, Sood B, Warwicker P, Brown H, Pattison J, Bhandari S, Barratt J, Turner N, Cook HT, Levy JB, Lightstone L, Pusey C, Galliford J, Cairns TD, Griffith M. Medjeral-Thomas NR, et al. Clin J Am Soc Nephrol. 2020 Feb 7;15(2):209-218. doi: 10.2215/CJN.06180519. Epub 2020 Jan 17. Clin J Am Soc Nephrol. 2020. PMID: 31953303 Free PMC article. Clinical Trial.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This was a multicenter, prospective, open-label, randomized, controlled trial involving six nephrology units across the United Kingdom. Adult patients with first presentation of minimal change disease and nephrotic …
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This was a multicenter, prospective, open-label, randomized, controlled trial …
Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis.
Mariani LH, Eddy S, AlAkwaa FM, McCown PJ, Harder JL, Nair V, Eichinger F, Martini S, Ademola AD, Boima V, Reich HN, El Saghir J, Godfrey B, Ju W, Tanner EC, Vega-Warner V, Wys NL, Adler SG, Appel GB, Athavale A, Atkinson MA, Bagnasco SM, Barisoni L, Brown E, Cattran DC, Coppock GM, Dell KM, Derebail VK, Fervenza FC, Fornoni A, Gadegbeku CA, Gibson KL, Greenbaum LA, Hingorani SR, Hladunewich MA, Hodgin JB, Hogan MC, Holzman LB, Jefferson JA, Kaskel FJ, Kopp JB, Lafayette RA, Lemley KV, Lieske JC, Lin JJ, Menon R, Meyers KE, Nachman PH, Nast CC, O'Shaughnessy MM, Otto EA, Reidy KJ, Sambandam KK, Sedor JR, Sethna CB, Singer P, Srivastava T, Tran CL, Tuttle KR, Vento SM, Wang CS, Ojo AO, Adu D, Gipson DS, Trachtman H, Kretzler M. Mariani LH, et al. Kidney Int. 2023 Mar;103(3):565-579. doi: 10.1016/j.kint.2022.10.023. Epub 2022 Nov 25. Kidney Int. 2023. PMID: 36442540 Free PMC article.
The diagnosis of nephrotic syndrome relies on clinical presentation and descriptive patterns of injury on kidney biopsies, but not specific to underlying pathobiology. ...Thus, molecular profiling identified a subgroup of patients with either MCD or FSGS who shared kidney …
The diagnosis of nephrotic syndrome relies on clinical presentation and descriptive patterns of injury on kidney biopsies, but not sp …
Cyclosporine in the treatment of idiopathic nephrosis.
Niaudet P, Habib R. Niaudet P, et al. J Am Soc Nephrol. 1994 Oct;5(4):1049-56. doi: 10.1681/ASN.V541049. J Am Soc Nephrol. 1994. PMID: 7849244 Review.
Within the past decade, there have been numerous reports on the use of cyclosporine in idiopathic nephrosis. In this review, the results of both uncontrolled and controlled studies of the therapeutic effects of cyclosporine in steroid-sensitive/dependent idiopathic neph …
Within the past decade, there have been numerous reports on the use of cyclosporine in idiopathic nephrosis. In this review, the resu …
The role of B7-1 in proteinuria of glomerular origin.
Novelli R, Benigni A, Remuzzi G. Novelli R, et al. Nat Rev Nephrol. 2018 Sep;14(9):589-596. doi: 10.1038/s41581-018-0037-z. Nat Rev Nephrol. 2018. PMID: 29959373 Review.
Moreover, we highlight crucial issues that should be addressed urgently - such as standardization of sample processing time, material conservation and antibody usage in immunohistochemical protocols - as a clinical trial that is investigating the efficacy of B7-1 bl …
Moreover, we highlight crucial issues that should be addressed urgently - such as standardization of sample processing time, material conser …
Treatment of childhood nephrotic syndrome.
Mendoza SA, Tune BM. Mendoza SA, et al. J Am Soc Nephrol. 1992 Oct;3(4):889-94. doi: 10.1681/ASN.V34889. J Am Soc Nephrol. 1992. PMID: 1450365 Clinical Trial.
The protocol appears to improve the outcome in children with focal segmental glomerulosclerosis, although it is believed that it is essential that these observations be confirmed by a controlled trial. There is also interest in the use of angiotensin-converting enzyme inhi …
The protocol appears to improve the outcome in children with focal segmental glomerulosclerosis, although it is believed that it is essentia …
Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children.
Ravani P, Bonanni A, Rossi R, Caridi G, Ghiggeri GM. Ravani P, et al. Clin J Am Soc Nephrol. 2016 Apr 7;11(4):710-20. doi: 10.2215/CJN.08500815. Epub 2015 Nov 19. Clin J Am Soc Nephrol. 2016. PMID: 26585985 Free PMC article. Review.
In this review, we present results of clinical studies that support rituximab as an effective steroid-sparing agent in steroid-dependent idiopathic nephrotic syndrome. ...Insufficient data are available on optimal use of rituximab as a maintenance steroid-sparing agent in …
In this review, we present results of clinical studies that support rituximab as an effective steroid-sparing agent in steroid-depend …
Mycophenolate mofetil in primary glomerulopathies.
Sepe V, Libetta C, Giuliano MG, Adamo G, Dal Canton A. Sepe V, et al. Kidney Int. 2008 Jan;73(2):154-62. doi: 10.1038/sj.ki.5002653. Epub 2007 Nov 7. Kidney Int. 2008. PMID: 17989649 Free article. Review.
None of these studies attained level A evidence, meaning that randomized control trials of sufficient statistical significance are necessary to estimate the real effectiveness of mycophenolate mofetil in primary glomerulopathies....
None of these studies attained level A evidence, meaning that randomized control trials of sufficient statistical significance are ne …
1,291 results